LUGARESI, Alessandra
 Distribuzione geografica
Continente #
EU - Europa 8.936
NA - Nord America 8.270
AS - Asia 4.455
SA - Sud America 217
Continente sconosciuto - Info sul continente non disponibili 21
AF - Africa 12
OC - Oceania 6
Totale 21.917
Nazione #
US - Stati Uniti d'America 8.226
IT - Italia 2.393
CN - Cina 1.567
UA - Ucraina 1.562
SG - Singapore 1.427
IE - Irlanda 1.338
TR - Turchia 1.074
GB - Regno Unito 996
SE - Svezia 715
FR - Francia 655
DE - Germania 501
FI - Finlandia 342
RU - Federazione Russa 218
IN - India 200
BR - Brasile 196
NL - Olanda 71
IR - Iran 37
CA - Canada 34
VN - Vietnam 34
HK - Hong Kong 33
CZ - Repubblica Ceca 22
JP - Giappone 22
EU - Europa 21
BE - Belgio 20
AT - Austria 18
IL - Israele 16
ES - Italia 15
PL - Polonia 13
CH - Svizzera 10
GR - Grecia 10
MX - Messico 9
AR - Argentina 8
DK - Danimarca 8
KR - Corea 8
BD - Bangladesh 7
AU - Australia 6
LT - Lituania 6
EC - Ecuador 5
MK - Macedonia 5
IQ - Iraq 4
RS - Serbia 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
EG - Egitto 3
HR - Croazia 3
MA - Marocco 3
RO - Romania 3
TW - Taiwan 3
KZ - Kazakistan 2
LU - Lussemburgo 2
PK - Pakistan 2
PY - Paraguay 2
UY - Uruguay 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CL - Cile 1
HU - Ungheria 1
ID - Indonesia 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
LB - Libano 1
LV - Lettonia 1
ME - Montenegro 1
MM - Myanmar 1
MZ - Mozambico 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
TH - Thailandia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
Totale 21.917
Città #
Jacksonville 1.782
Chandler 1.482
Dublin 1.327
Singapore 963
Southend 794
Princeton 616
Izmir 599
Nanjing 462
Wilmington 348
Cambridge 302
Beijing 251
The Dalles 214
Santa Clara 212
Ashburn 209
Altamura 199
Nanchang 181
Dearborn 157
Ann Arbor 150
Woodbridge 130
Rome 120
Milan 106
Boardman 96
Shenyang 93
Jiaxing 88
New York 88
Hebei 81
Chieti 75
Kunming 74
Tianjin 69
Norwalk 64
Houston 59
Los Angeles 51
Grevenbroich 46
Hangzhou 45
Changsha 42
Bologna 41
Naples 41
San Mateo 39
Torino 39
Helsinki 36
Florence 35
Washington 34
Dong Ket 33
Hong Kong 32
Leawood 30
Ardabil 29
Bari 26
Turin 26
Augusta 25
Moscow 25
Orange 25
Jinan 24
Munich 23
Lanzhou 21
Changchun 20
Verona 20
Brno 19
Nuremberg 19
Genoa 18
Guangzhou 18
London 17
Palermo 17
Pisa 17
São Paulo 17
Brussels 15
Catania 15
Cedar Knolls 15
Monmouth Junction 15
Ningbo 15
Campobasso 14
Padova 13
Pescara 13
Seattle 13
Toronto 13
Catanzaro 12
Genova 12
Hanover 12
Zhengzhou 12
Falls Church 11
Auburn Hills 10
Frankfurt am Main 10
Taizhou 10
Casièr 9
Parma 9
Poggio Picenze 9
Rio de Janeiro 9
Tappahannock 9
Trieste 8
Venezia 8
Andover 7
Belo Horizonte 7
Hefei 7
Massa E Cozzile 7
Mumbai 7
Napoli 7
Reggio Calabria 7
San Francisco 7
Teramo 7
Turku 7
Vicenza 7
Totale 12.709
Nome #
La risposta simpatica cutanea: basi neurofisiologiche, valori normativi, applicazioni cliniche 1.520
The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian population 363
Ruolo degli anticorpi anti-gangliosidi nelle neuropatie e nelle malattie del motoneurone 189
Miastenia gravis "distale" e neuronopatia sensitiva simulanti una neuropatia sensori-motoria 187
Un caso di mieloneuropatia da HTLV- I in Italia 184
Polineuropatia assonale cronica progressiva sensibile al trattamento steroideo: una neuropatia assonale primitiva o una variante della poliradicoloneuropatia cronica ingiammatoria demielinizzante? 165
An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis 154
IL 13 in multiple sclerosis 130
Anti-GD1a Antibodies from Acute Motor Axonal Neuropathy Patients Selectively Bind to Ranvier Nodes of Motor Nerve Fibers 125
Cleavage of cystatin C is not associated with multiple sclerosis 115
The brief international cognitive assessment for multiple sclerosis (bicams): normative values in the Italian population. 113
Amplifications of multiple regions of the HTLV-I genome from DNA of an Italian spastic paraparesis patient but not from DNA of multiple sclerosis patients. 113
A lipidomic investigation for the caracterisation of CSF lipid profile in patients with multiple sclerosis 108
Utilità dell'ecobiometria del nervo ottico nella diagnosi e nel follow-up della neurite ottica retrobulbare 107
Studio comparativo multicentrico sulla misurazione degli anticorpi IgM ANTI-GM1 nel siero di pazienti con neuropatia motoria multifocale e sclerosi laterale amiotrofica 106
A computational platform for MALDI-TOF mass spectrometry data: Application to serum and plasma samples 105
The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Normative Values With Gender, Age And Education Corrections In The Italian Population (P5.015) 105
"Minimal" chronic inflammatory demyelinating polyneuropathy 104
Utilità della tecnica destir (RM) nella diagnosi di neurite ottica retrobulbare 102
The Multiple Sclerosis Knowledge Questionnaire: a self administered instrument for recently diagnosed patients 102
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP) ASSOCIATED WITH MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS 102
Independent component analysis for the extraction of reliable protein signal profiles from MALDI-TOF mass spectra 101
Effetti sinergici della terapia con interferone-beta sulla attivazione, adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante/remittente 101
Anti-GD1a antibodies from an acute motor axonal neuropathy patient selectively bind to motor nerve fiber nodes of Ranvier 100
La funzione soppressoria è ridotta nella polineuropatia demielinizzante cronica infiammatoria (CIDP) 98
Chemokines are Modulated by Interferon beta 1B (IFNT-Beta IB) in Relapsing-Remitting Multiple Sclerosis (RR-MS) 97
Increasing age at disability milestones among MS patients in the MSBase Registry 97
Anti-glycolipid and anti-tubulin antibodies in chronic inflammatory demyelinating polyneuropathy 96
Metabolomics analysis of cerebrospinal fluid reveals a distintive biochemical alteration associated with multiple sclerosis. 96
Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis 96
Rantes Levels and mRNA Expression in Relapsing-Remitting Multiple Sclerosis (RR-MS): Effect of interferon Beta 1b (IFNBeta 1b) Treatment 95
Adhesion molecule expression in sural nerve of chronic inflammatory demyelinating polineuropaty 94
F response in vascular and degenerative upper motor neuron lesions 93
Transdermal scopolamine cycloplegia in juvenile diabetes 93
Acute motor conduction block neuropathy Another Guillain-Barré syndrome variant. 93
Chronic inflammatory demyelinating polyneuropathy in diabetes 92
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. 92
Neurite ottica retrobulbare: studio biometrico del nervo ottico 91
Autoimmunity and interferon beta1B 91
Binding of Anti GD1 a Antibodies in Peripheral Nerve. Abstracts of the 4th Meeting of the Italian Peripheral Nerve Study Group - Chieti, March 26-27 1999 91
Dysimmune demyelinating polyneuropathies: expression of adhesion molecules in sural nerves and changes in cellular immunity (suppressor cell function and cytokine mRNA expression) induced by treatment (progetto presentato a Telethon) 91
TLC-MALDI-Imaging approach for lipidomics studies in cerebrospinal fluid reveals low levels of sphingomyelin in multiple sclerosis patients 89
Chemokine production by mononuclear cells from relapsing-remitting multiple sclerosis (RR-MS) patients 89
Effect of TNF intraneural injection into the rat sciatic nerve 88
Anti-ganglioside antibodies in the Guillain-Barré syndrome (GBS): a case control study 88
Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS. 88
Rantes and MCP-1 Secretion by Mononuclear Cells of Patients with Nultiple Sclerosis 87
Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei 87
Prednisone and plasma exchange improve suppressor cell function in chronic inflammatory demyelinating polyneuropathy. 87
MCP-1 expression and secretion in adherent monocyte cultures from multiple sclerosis patients treated with interferon beta-1b 86
The Chieti experience with Interferon B1b (IFNB1b) during the first 2 years: side effects. 85
Recurrent cranial nerve palsies, midbrain infarction and hydrocephalus due to megadolichobasilar artery 85
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 85
Interferon beta normalizes suppressor cell function in dysimmune neuropathies. 85
Interferon beta1b: the Chieti experience 84
The Chieti Experience with interferon B1b (IFNB1b) during the first 2 years: Efficacy 84
Chronic inflammatory demyelinating polyneuropathy in diabetes mellitus 84
Convulsive status epilepticus due to new encephalic demyelinating lesions in multiple sclerosis 84
Development of methods for lipid extraction from CSF and application of mass spectometry techniques for the characterization of the lipid profile and neurosteroids levels in MS patients 84
May electrophysiology differentiate chronic inflammatory demyelinating polyneuropathy (CIDP) and polineuropathy with anti- SGPG antibodies? 83
Addressing the need for increased adherence to multiple sclerosis therapy: can delivery technology enhance patient motivation? 83
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis 83
Effect of the disclosure of MS diagnosis on anxiety, mood and quality of life of patients: a prospective study 83
Neurite ottica: relazione tra perimetria, PEV e RMN 82
Effects of IL10 on recombinant interferon-beta1b stimulated suppressor cell function in MS and controls subjects 82
Plasma exchange and prednisone improve suppressor cell function in dysimmune neuropathies 82
Effetti sinergici della terapia con interferone-beta sulla attivazione. Adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante /remittente. (C22) 82
Effect of rhTNF-alpha injection into rat sciatic nerve 82
Anti-JCV serostatus, index value and clinical features in patients affected by multiple sclerosis. 82
Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis 81
Anti-glicolipid antibodies in chronic inflammatory demyelinating polyneuropathy (CIDP) 81
Interferon beta normalizes suppressor cell function in dysimmune neuropathies 81
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. 81
Brain tissue loss occurs after suppression of enhancement in patients with multiple scerosis treated with autologous haematopoietic stem cell transplantation. 80
Sclerosi multipla: meccanismi patogenetici alla base della demielinizzazione 80
Serum soluble adhesion molecules and proinflammatory cytokines are not increased in chronic inflammatory demyelinating polyneuropathy 79
Acute motor axonal neuropathy with high titer IgG and IgA anti-GD1a antibodies following Campylobacter enteritis 79
TheND1 gene of complex I is a mutational hot spot for Leber’s hereditary optic neuropathy 79
Patterns in patients’expression of emotions and neurologists’ response. 79
Extrapyramidal syndrome and depression induced by flunarizine 79
Cognitive dysfunction in patients with relapsing-remitting Multiple Sclerosis 79
Interferon therapy in dysimmune neuropathies 78
Expression of adhesion molecules in sural nerve of chronic inflammatory demyelinating polyneuropathy (CIDP) 78
Caratteristiche elettrofisiologiche della polineuropatia acuta assonale motoria associata ad elevato titolo di anticorpi anti-GD1a 77
OXIDATIVE MODIFICATIONS OF CEREBRAL TRANSTHYRETIN ARE ASSOCIATED WITH MULTIPLE SCLEROSIS 77
Demyelinating motor Guillain-Barré syndrome following Rubella 77
Aspetti immunologici delle poliradicoloneuriti croniche 76
Comparison of Switch to Fingolimod or Interferon Beta/Glatiramer Acetate in Active Multiple Sclerosis 76
rlFN-beta-1B stimulated suppressor cell function in multiple sclerosis: effects of anti-IL-10 monoclonal antibody 76
Interferone beta: effetti collaterali 76
Real-life impact of early interferon beta therapy in relapsing multiple sclerosis 76
76.Distal myasthenia gravis and sensory neuronopathy with anti-50 kDa antibody mimicking sensory-motor neuropathy. 76
Protein profiling of Guillain-Barrè Syndrome cerebrospinal fluid by two dimensional electrophoresis and mass spectrometry. 76
JCV-Ab serostatus in MS patients treated with Natalizumab 76
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy. 76
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 76
Shared T Cell Receptor Usage of Cerebrospinal Fluid Cells in Familial Multiple Sclerosis da: X° National A.I.N.I. Congress Association Italiana Neuroimmunologia - Florence, Italy, November 15/16,1999 75
Chemokine secretion by mononuclear cells of patients with multiple sclerosis (MS) 75
Lack of vegetative and endocrine circadian rhythms in fatal familial thalamic degeneration 75
Can electrophysiology differentiate polyneuropathy with anti-MAG/SGPG antibodies from chronic inflammatory demyelinating polyneuropathy? 75
Totale 10.975
Categoria #
all - tutte 89.313
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.313


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020419 0 0 0 0 0 0 0 0 0 0 392 27
2020/20211.936 317 10 312 18 154 388 19 14 176 218 183 127
2021/20221.200 13 21 19 193 62 35 42 99 94 27 198 397
2022/20234.212 376 504 192 499 416 851 290 302 488 55 129 110
2023/20241.870 152 105 109 52 84 545 465 75 24 43 37 179
2024/20253.483 342 773 737 77 87 141 117 261 396 243 309 0
Totale 22.148